Council to Advance Human Health

The Council to Advance Human Health (CAHH) is a non-profit organization dedicated to accelerating the transition of academic medical discoveries into commercial products that improve human health. It provides strategic guidance, industry mentorship, and proof-of-concept funding to researchers, helping them reach critical value-inflection points. CAHH primarily focuses on de-risking early-stage technologies from academic institutions like Columbia University to make them more attractive for industry licensing or venture capital investment. The organization's portfolio spans a wide range of modalities, including small molecules, biologics, and medical devices, across various therapeutic areas. By bridging the gap between basic science and clinical development, CAHH plays a vital role in the life sciences ecosystem.